Compare Enveric Biosciences Inc (ENVB) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Vanguard Real Estate Index Fund ETF trades at $90.1 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 10411.8× Enveric Biosciences Inc's market cap, and Vanguard Real Estate Index Fund ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Vanguard Real Estate Index Fund ETF for 112 Days on average.
| ENVB | VNQ | |
|---|---|---|
Market Cap | $6.80M | $70.80B |
Volume | 64,867 | 6,073,580 |
Sector | Health | — |
52-Week High | $10.80 | $100.95 |
52-Week Low | $1.27 | $87.00 |
Typical Hold Time | 14 Days | 112 Days |
Enterprise Value | -$1.49M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
VNQ (Vanguard Real Estate ETF) trades at $88.69, down 1.38% on the day amid a bearish technical signal, with moving averages indicating a downtrend. Recent news highlights a sharp sector decline due to rising Treasury yields and Fed rate hikes, eroding its income appeal versus safer assets. The ETF's financial ratios are not applicable as it is a fund tracking REITs, but it offers a dividend yield with a recent $0.80 distribution scheduled for September 2026.
Outlook remains cautious with high interest rates pressuring REIT valuations, though contrarian investors see opportunity in oversold conditions. Risks include sustained rate hikes and economic slowdowns, while potential upside hinges on a Fed pivot. Institutional buying, such as State Street's recent share increase, suggests some confidence in long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
